Detalles de la búsqueda
1.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol;
: 1-19, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861289
2.
Analyses of tumor microenvironment in patients with advanced renal cell carcinoma receiving immunotherapy (Meet-URO 18 study).
Future Oncol;
: 1-19, 2024 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682738
3.
Apalutamide-induced lichenoid reaction in a patient with non-metastatic castrate-resistant prostate cancer.
J Oncol Pharm Pract;
29(7): 1748-1753, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37282554
4.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med;
20(1): 435, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180954
5.
Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient.
Anticancer Drugs;
33(1): e724-e729, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261919
6.
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
Clin Genitourin Cancer;
22(2): 126-133.e2, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932204
7.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol;
14: 1307635, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410103
8.
A novel immunotherapy prognostic score for patients with pretreated advanced urInary TrAct CArcinoma from the subgroup analysis of the SAUL study: the ITACA Score.
Minerva Urol Nephrol;
75(3): 308-318, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36511379
9.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study.
Cancers (Basel);
15(8)2023 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190322
10.
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report.
Immunotherapy;
14(18): 1419-1427, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597723
11.
Immunotherapy retreatment: case report, review of the literature and proposal for the definition of different scenarios.
Immunotherapy;
13(8): 645-652, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823647
12.
Prognostic and Predictive Factors in Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors: A Review of the Current Evidence.
Cancers (Basel);
13(21)2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771680
13.
Gender-specific aspects related to type of fertility preservation strategies and access to fertility care.
ESMO Open;
5(Suppl 4): e000771, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33115753
14.
Burning Questions in the Oncofertility Counseling of Young Breast Cancer Patients.
Breast Cancer (Auckl);
14: 1178223420954179, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32952399
15.
The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study.
Cancers (Basel);
12(11)2020 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33142739
16.
Moving trastuzumab emtansine (T-DM1) to the early setting of breast cancer treatment.
Ann Palliat Med;
9(2): 512-516, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32233615
Resultados
1 -
16
de 16
1
Próxima >
>>